Swedish care provider Ambea has acquired the rival care operations of Aleris in Sweden, Norway and Denmark for SEK 2.6bn (€252m), 14x EBITA. Healthcare Europa speaks to Ambea CEO Frederik Gren.
A member of the senior management team at an international health insurance provider tells Healthcare Nova that an experiment with premiums has tripled the take-up of telehealth in one of their markets.
Specialist diagnostics lab company Strand Lifesciences has bought the Indian medical diagnostics arm of Quest Diagnostics. Healthcare Nova speaks to its CEO about the deal, and how the two companies will continue working together going forward.
Some of the largest lab groups in the world have banded together to form the "Global Diagnostics Network", an international alliance led by US-lab giant Quest Diagnostics.
Private equity firm Terra Firma has put 24 care homes up for sale in the UK for £225m (€256m), following a court case in which US-investment fund H/2 Capital partners disputed their ownership.
A small band of NHS doctors has begun offering 30-minute consultations and handing out their mobile numbers to patients for £1,200 a year, as part of a new private scheme based on a US model. We speak to Dr Mark Sweeney, director of Concierge Choice UK which is behind the move, to find out more.
A new hospital to be built in Lagos as part of an urban development project is looking for investors. We speak to the broker of the deal at real-estate brokerage firm Coldwell Banker Netherland (CBN).
Investors were less than impressed by Netcare's recent announcement that earnings for the year to September 30 would be lower than last year - dropping its share value by almost 13% before a slight recovery. Netcare blamed "difficult trading conditions" but it is not the only one feeling the heat at home - Life and Mediclinic have also seen their values drop in the last six months. We talk to a South Africa based healthcare expert to find out what's wrong with the market.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
